[HTML][HTML] Recent progress and perspectives on prostate cancer biomarkers
S Hatakeyama, T Yoneyama, Y Tobisawa… - International journal of …, 2017 - Springer
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening,
diagnosis, and prognosis has improved the clinical management of PC patients. However …
diagnosis, and prognosis has improved the clinical management of PC patients. However …
Recent progress and perspectives on prostate cancer biomarkers
S Hatakeyama, T Yoneyama, Y Tobisawa… - International Journal of …, 2016 - infona.pl
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening,
diagnosis, and prognosis has improved the clinical management of PC patients. However …
diagnosis, and prognosis has improved the clinical management of PC patients. However …
[PDF][PDF] Recent progress and perspectives on prostate cancer biomarkers
S Hatakeyama, T Yoneyama, Y Tobisawa, C Ohyama - Int J Clin Oncol, 2017 - core.ac.uk
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening,
diagnosis, and prognosis has improved the clinical management of PC patients. However …
diagnosis, and prognosis has improved the clinical management of PC patients. However …
[PDF][PDF] Recent progress and perspectives on prostate cancer biomarkers
S Hatakeyama, T Yoneyama, Y Tobisawa, C Ohyama - 2016 - researchgate.net
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening,
diagnosis, and prognosis has improved the clinical management of PC patients. However …
diagnosis, and prognosis has improved the clinical management of PC patients. However …
Recent progress and perspectives on prostate cancer biomarkers
S Hatakeyama, T Yoneyama… - … journal of clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening,
diagnosis, and prognosis has improved the clinical management of PC patients. However …
diagnosis, and prognosis has improved the clinical management of PC patients. However …
Recent progress and perspectives on prostate cancer biomarkers
S Hatakeyama, T Yoneyama… - … Journal of Clinical …, 2017 - search.proquest.com
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening,
diagnosis, and prognosis has improved the clinical management of PC patients. However …
diagnosis, and prognosis has improved the clinical management of PC patients. However …
[引用][C] Recent progress and perspectives on prostate cancer biomarkers
S HATAKEYAMA, T YONEYAMA… - … Journal of Clinical …, 2017 - jglobal.jst.go.jp
Koie T, Mitsuzuka K, Yoneyama T et al (2015) Prostate-specific antigen density predicts
extracapsular extension and increased risk of biochemical recurrence in patients with high …
extracapsular extension and increased risk of biochemical recurrence in patients with high …
Recent progress and perspectives on prostate cancer biomarkers.
S Hatakeyama, T Yoneyama, Y Tobisawa… - International Journal of …, 2016 - europepmc.org
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening,
diagnosis, and prognosis has improved the clinical management of PC patients. However …
diagnosis, and prognosis has improved the clinical management of PC patients. However …
Recent progress and perspectives on prostate cancer biomarkers.
S Hatakeyama, T Yoneyama… - … Journal of Clinical …, 2017 - search.ebscohost.com
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening,
diagnosis, and prognosis has improved the clinical management of PC patients. However …
diagnosis, and prognosis has improved the clinical management of PC patients. However …
[PDF][PDF] Recent progress and perspectives on prostate cancer biomarkers
S Hatakeyama, T Yoneyama, Y Tobisawa, C Ohyama - 2016 - cyberleninka.org
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening,
diagnosis, and prognosis has improved the clinical management of PC patients. However …
diagnosis, and prognosis has improved the clinical management of PC patients. However …